Jeanine Pignatelli

Jeanine Pignatelli has worked in a variety of roles in the biotechnology industry. Jeanine began their career in 2005 as a Graduate Research Assistant at the State University of New York Upstate Medical University. Jeanine then moved to Albert Einstein College of Medicine in 2012, where they served as a Postdoctoral Research Fellow. In 2016, they joined Pfizer as a Senior Scientist Oncology. In 2018, they moved to Boehringer Ingelheim as a Principal Scientist/Lab Head and Project Lead. Most recently, they were appointed Director, Head of Biology at Mestag Therapeutics in 2022.

Jeanine Pignatelli obtained their Doctor of Philosophy (PhD) in Cell Biology and Anatomy from the State University of New York Upstate Medical University between 2005 and 2012. In October 2017, they also obtained a certification in Clinical Research Management.